Northcape Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15M | Sell |
11,583
-5
| -0% | -$928 | 0.66% | 47 |
|
|
2025
Q1 | $2.43M | Buy |
11,588
+1
| +0% | +$210 | 0.78% | 39 |
|
|
2024
Q4 | $2.06M | Sell |
11,587
-1,095
| -9% | -$195K | 0.67% | 50 |
|
|
2024
Q3 | $2.5M | Buy |
12,682
+900
| +8% | +$178K | 0.82% | 45 |
|
|
2024
Q2 | $2.02M | Buy |
11,782
+1,253
| +12% | +$215K | 0.73% | 47 |
|
|
2024
Q1 | $1.92M | Sell |
10,529
-1,509
| -13% | -$275K | 0.7% | 50 |
|
|
2023
Q4 | $1.87M | Sell |
12,038
-191
| -2% | -$29.6K | 0.68% | 51 |
|
|
2023
Q3 | $1.82M | Sell |
12,229
-536
| -4% | -$79.9K | 0.7% | 49 |
|
|
2023
Q2 | $1.72M | Sell |
12,765
-341
| -3% | -$45.9K | 0.62% | 55 |
|
|
2023
Q1 | $2.09M | Buy |
+13,106
| New | +$2.09M | 0.76% | 45 |
|
|
2022
Q4 | – | Sell |
-14,290
| Closed | -$1.92M | – | 75 |
|
|
2022
Q3 | $1.92M | Buy |
14,290
+1,876
| +15% | +$252K | 0.68% | 54 |
|
|
2022
Q2 | $1.9M | Sell |
12,414
-1,580
| -11% | -$242K | 0.73% | 47 |
|
|
2022
Q1 | $2.27M | Buy |
13,994
+1,977
| +16% | +$321K | 0.66% | 50 |
|
|
2021
Q4 | $1.63M | Buy |
+12,017
| New | +$1.63M | 0.55% | 55 |
|